Safety of Recombinant Influenza Vaccine Compared to Inactivated Influenza Vaccine in Adults: An Observational Study

BACKGROUND: Recombinant trivalent influenza vaccine (RIV3) was initially licensed in 2013 and approved for all adults ≥18 in 2014. This study evaluated the safety of RIV3 compared with trivalent standard-dose, inactivated influenza vaccine (IIV3) in Kaiser Permanente Northern California (KPNC). METH...

Descripción completa

Detalles Bibliográficos
Autores principales: Hansen, John, Goddard, Kristin, Timbol, Julius, Zhang, Lea, Lewis, Ned, Dunkle, Lisa, Izikson, Ruvim, Klein, Nicola P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7316363/
https://www.ncbi.nlm.nih.gov/pubmed/32617368
http://dx.doi.org/10.1093/ofid/ofaa179

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7316363/
https://www.ncbi.nlm.nih.gov/pubmed/32617368
http://dx.doi.org/10.1093/ofid/ofaa179

Ejemplares similares